Skip to content
PeptideAgent

Telehealth providers in Indiana

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in Indiana. What Indiana requires of telehealth prescribers and pharmacies, plus verified listings.

Indiana at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving Indiana

No verified telehealth providers serving Indiana are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in Indiana

Indiana Code 25-1-9.5 (Telehealth Services and Prescriptions) bars a prescriber from treating or prescribing for a patient located in Indiana by telehealth unless a provider-patient relationship exists, but allows that relationship to be established through telehealth. At a minimum the prescriber must obtain the patient's name, contact information, and location and, as far as reasonably possible, verify identity, must create and keep a medical record, and must notify the patient's primary care provider of prescriptions issued if the patient supplies that contact information. The chapter defines store and forward (transmission of medical information without the patient present) as part of telehealth. Telehealth providers must hold an Indiana license (Indiana is an Interstate Medical Licensure Compact state, which is one route). Section 25-1-9.5-7 also requires the practitioner to obtain informed consent and the medical history needed for a diagnosis, discuss the diagnosis, the evidence for it, and the risks and benefits of treatment options, give follow-up instructions, and provide a visit summary listing any prescription. Section 25-1-9.5-8 lets a prescriber issue a non-opioid prescription to a telehealth patient never examined in person if the standard of care is met, and requires a real-time, two-way audiovisual connection only for controlled substances. The chapter does not say whether an asynchronous-only intake can satisfy the section 7 elements for a first non-controlled prescription, so async_prescribing_allowed is left unknown. [2] [3] [4] [7] [13]

Compounded GLP-1 access in Indiana

Compounded semaglutide and tirzepatide are limited to documented patient-specific needs after the FDA shortage allowances ended in 2025, and Indiana's 2026 law adds sourcing rules (FDA-registered bulk manufacturers with certificates of analysis) that exclude the unregistered active ingredient suppliers behind many cheap compounded GLP-1 products. Medical spas offering GLP-1 injections will need to register with the Medical Licensing Board from January 1, 2027. [8] [11]

Research use only sellers in Indiana

Only Indiana-licensed pharmacies, including licensed nonresident pharmacies, may dispense prescription drugs to Indiana patients, and Senate Enrolled Act 282 (2026) requires compounders to source bulk substances from FDA-registered establishments. Indiana Code 16-42-22.5, added by that act, expressly bars compounding with a research grade bulk substance outside an IRB-approved study. "Research use only" peptides sold for human injection are unapproved new drugs under federal law, are not dispensed by a pharmacist, and do not meet Indiana's new sourcing standard. [5] [8] [9] [12]

How to check a telehealth provider in Indiana

  1. Confirm the prescriber is licensed or registered to treat patients located in Indiana; the telehealth rules above explain what Indiana requires. [2] [3] [4] [7] [13]
  2. Ask which pharmacy will fill the prescription and check it in the Indiana Board of Pharmacy (Indiana Professional Licensing Agency) license lookup. [1] [5] [6] [8] [9] [10]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Indiana. [5] [8] [9] [12]

Common questions in Indiana

Can I start GLP-1 treatment in Indiana through telehealth?

Yes. Indiana Code 25-1-9.5 lets an Indiana-licensed prescriber establish a provider-patient relationship through telehealth, provided they verify who and where you are, keep a medical record, and meet the standard of care. They must also tell your primary care provider about the prescription if you share that contact. [2] [7]

What does an out-of-state pharmacy need to ship compounded peptides to Indiana?

An Indiana nonresident pharmacy license from the Indiana Board of Pharmacy under Indiana Code 25-26-17. Check the Professional Licensing Agency lookup before ordering. [1] [9]

All peptide legal questions for Indiana

Sources

  1. [1]Indiana Board of Pharmacy, Indiana Professional Licensing Agency
  2. [2]Indiana Code Title 25, Article 1, Chapter 9.5, Telehealth services and prescriptions
  3. [3]Indiana Code 25-1-9.5-7, Standards for providing telehealth
  4. [4]Indiana Code 25-1-9.5-8, Issuance of prescription; controlled substance conditions
  5. [5]Senate Enrolled Act 282 (2026), enrolled text, Public Law 136, adding Indiana Code 16-42-22.5
  6. [6]856 Indiana Administrative Code Article 1, Pharmacies and Pharmacists (including Rule 30, sterile pharmaceuticals)
  7. [7]Indiana Professional Licensing Agency: telehealth
  8. [8]Indiana General Assembly, Senate Bill 282 (2026), Compounding drugs; registration of medical spas
  9. [9]Indiana Code Title 25, Article 26, Chapter 17, Nonresident pharmacies
  10. [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA